🇺🇸 FDA
Patent

US 11433038

High concentration medicant solutions for treating neurological disorders

granted A61KA61K31/19A61K45/06

Quick answer

US patent 11433038 (High concentration medicant solutions for treating neurological disorders) held by The Regents of the University of Colorado expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/19, A61K45/06, A61K47/12, A61K9/0019